Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatment of scleroderma.

D Meyers

    The Medical Journal of Australia
    |June 11, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Potassium para-aminobenzoate (KPAB) significantly improved scleroderma symptoms, including healing ulcers and enhancing mobility. This suggests KPAB may be more effective than resurpine for managing scleroderma progression.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Resonant inelastic x-ray scattering data for Ruddlesden-Popper and reduced Ruddlesden-Popper nickelates.

    Scientific data·2023
    Same author

    Enacting Treaty Rights through Restoring Shoshone Ancestral Foods on the Wind River Indian Reservation.

    Journal of poverty·2022
    Same author

    Charge Condensation and Lattice Coupling Drives Stripe Formation in Nickelates.

    Physical review letters·2021
    Same author

    Strong Superexchange in a d^{9-δ} Nickelate Revealed by Resonant Inelastic X-Ray Scattering.

    Physical review letters·2021
    Same author

    Author Correction: Local negative permittivity and topological phase transition in polar skyrmions.

    Nature materials·2021
    Same author

    Local negative permittivity and topological phase transition in polar skyrmions.

    Nature materials·2020

    Area of Science:

    • Rheumatology
    • Dermatology
    • Pharmacology

    Background:

    • Scleroderma is a chronic autoimmune disease characterized by hardening and tightening of the skin and connective tissues.
    • Current treatments aim to manage symptoms and slow disease progression, but effective therapies remain a focus of research.

    Observation:

    • A patient with scleroderma presented with significant symptoms including skin ulcers and joint stiffness.
    • The patient received treatment involving potassium para-aminobenzoate (KPAB) and resurpine.

    Findings:

    • The patient experienced considerable relief of scleroderma symptoms.
    • Observed improvements included the healing of ulcers and increased skin and joint mobility.
    • The progressive improvement was attributed primarily to potassium para-aminobenzoate (KPAB) rather than resurpine.

    Related Experiment Videos

    Implications:

    • Potassium para-aminobenzoate (KPAB) shows promise as an effective treatment for scleroderma.
    • Further clinical trials are warranted to validate the efficacy of KPAB in a larger scleroderma patient cohort.
    • This case highlights a potential therapeutic avenue for improving quality of life in scleroderma patients.